NEW YORK, Dec. 6, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders ...
Church & Dwight. has filed a patent for compositions and methods to convert oleuropein to hydroxytyrosol using Lactobacillus pentosus strain OL79 or active variants. The invention aims to increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback